Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer. [electronic resource] by
- Rody, A
- Karn, T
- Ruckhäberle, E
- Müller, V
- Gehrmann, M
- Solbach, C
- Ahr, A
- Gätje, R
- Holtrich, U
- Kaufmann, M
Producer: 20090210
In:
Breast cancer research and treatment vol. 113
Availability: No items available.
|
|
17.
|
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. [electronic resource] by
- Schmidt, M
- Victor, A
- Bratzel, D
- Boehm, D
- Cotarelo, C
- Lebrecht, A
- Siggelkow, W
- Hengstler, J G
- Elsässer, A
- Gehrmann, M
- Lehr, H-A
- Koelbl, H
- von Minckwitz, G
- Harbeck, N
- Thomssen, C
Producer: 20090417
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
18.
|
Role of the progesterone receptor for paclitaxel resistance in primary breast cancer. [electronic resource] by
- Schmidt, M
- Bremer, E
- Hasenclever, D
- Victor, A
- Gehrmann, M
- Steiner, E
- Schiffer, I B
- Gebhardt, S
- Lehr, H-A
- Mahlke, M
- Hermes, M
- Mustea, A
- Tanner, B
- Koelbl, H
- Pilch, H
- Hengstler, J G
Producer: 20070305
In:
British journal of cancer vol. 96
Availability: No items available.
|
|
19.
|
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer. [electronic resource] by
- Darb-Esfahani, S
- Kronenwett, R
- von Minckwitz, G
- Denkert, C
- Gehrmann, M
- Rody, A
- Budczies, J
- Brase, J C
- Mehta, M K
- Bojar, H
- Ataseven, B
- Karn, T
- Weiss, E
- Zahm, D M
- Khandan, F
- Dietel, M
- Loibl, S
Producer: 20130307
In:
British journal of cancer vol. 107
Availability: No items available.
|
|
20.
|
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer. [electronic resource] by
- Dubsky, P
- Filipits, M
- Jakesz, R
- Rudas, M
- Singer, C F
- Greil, R
- Dietze, O
- Luisser, I
- Klug, E
- Sedivy, R
- Bachner, M
- Mayr, D
- Schmidt, M
- Gehrmann, M C
- Petry, C
- Weber, K E
- Kronenwett, R
- Brase, J C
- Gnant, M
Producer: 20130730
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|